Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference

Registration Link for Presentation to take place Thursday, May 22, 2025 at 10:00 AM ET May 19, 2025 7:45 AM EDT | Source: Phio Pharmaceuticals Corp. Marlborough, Massachusetts--(Newsfile Corp. - May 19, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will ...